HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

P Tiberghien Selected Research

Epstein-Barr virus glycoprotein gp110

7/2000Decreased T cell precursor frequencies to Epstein-Barr virus glycoprotein Gp110 in peripheral blood correlate with disease activity and severity in patients with rheumatoid arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


P Tiberghien Research Topics

Disease

10Graft vs Host Disease (Graft-Versus-Host Disease)
01/2016 - 02/2000
4Infections
02/2015 - 08/2000
3Neoplasms (Cancer)
11/2021 - 01/2016
3Inflammation (Inflammations)
07/2013 - 07/2000
3Leukemia
07/2013 - 06/2000
3Hemolysis
09/2001 - 03/2000
3Rheumatoid Arthritis
03/2001 - 03/2000
3Herpes Simplex
01/2001 - 02/2000
2Spondylarthropathies
02/2006 - 04/2003
2Bronchiolitis Obliterans Syndrome
09/2001 - 02/2000
1COVID-19
11/2021
1Clinical Deterioration
11/2021
1Wounds and Injuries (Trauma)
11/2019
1Hemorrhage
11/2019
1Carcinoma (Carcinomatosis)
01/2018
1Anemia
01/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Thrombocytopenia (Thrombopenia)
01/2018
1Myeloid Leukemia (Leukemia, Myelocytic)
01/2018
1Opportunistic Infections (Opportunistic Infection)
04/2015
1Reinfection
02/2015
1End Stage Liver Disease
02/2015
1Liver Diseases (Liver Disease)
02/2015
1Sacroiliitis
04/2003
1Ankylosing Spondylitis
04/2003
1Sarcoma (Soft Tissue Sarcoma)
12/2002
1Polyarteritis Nodosa (Periarteritis Nodosa)
05/2002
1Genetic Predisposition to Disease (Genetic Predisposition)
03/2001
1Hematologic Neoplasms (Hematological Malignancy)
01/2001
1Necrosis
09/2000
1Alveolar echinococcosis
09/2000
1Joint Diseases (Joint Disease)
07/2000
1Epstein-Barr Virus Infections
07/2000
1Lymphoma (Lymphomas)
05/2000
1Vitiligo
02/2000

Drug/Important Bio-Agent (IBA)

5Thymidine KinaseIBA
01/2001 - 02/2000
4Ganciclovir (Cytovene)FDA LinkGeneric
01/2001 - 02/2000
3Proteins (Proteins, Gene)FDA Link
12/2002 - 05/2000
3AntigensIBA
05/2001 - 07/2000
2C-Reactive ProteinIBA
04/2003 - 07/2000
2EpitopesIBA
03/2001 - 07/2000
2CytokinesIBA
09/2000 - 08/2000
1etesevimabIBA
11/2021
1Cetuximab (Erbitux)FDA Link
01/2018
1AP 1903 reagentIBA
01/2016
1Antiviral Agents (Antivirals)IBA
02/2015
1Interleukin-22 (IL-22)IBA
07/2013
1HLA-B27 Antigen (HLA B27 Antigen)IBA
02/2006
1Histocompatibility Antigens Class IIBA
02/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2003
1Intravenous Immunoglobulins (IVIG)FDA Link
05/2002
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
07/2001
1Interleukin-7 (Interleukin 7)IBA
07/2001
1AntibodiesIBA
05/2001
1HLA-DRB1 Chains (HLA DRB1)IBA
03/2001
1HLA Antigens (Human Leukocyte Antigens)IBA
01/2001
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2001
1Interferon-gamma (Interferon, gamma)IBA
09/2000
1Interleukin-5 (Interleukin 5)IBA
09/2000
1Interleukin-10 (Interleukin 10)IBA
09/2000
1Biomarkers (Surrogate Marker)IBA
07/2000
1HLA-DR Antigens (HLA-DR)IBA
07/2000
1Epstein-Barr virus glycoprotein gp110IBA
07/2000
1Cyclosporine (Ciclosporin)FDA LinkGeneric
03/2000
1Oligonucleotide ProbesIBA
03/2000
1HLA-DM antigens (HLA-DMA)IBA
03/2000
1Methotrexate (Mexate)FDA LinkGeneric
03/2000

Therapy/Procedure

10Transplantation
04/2015 - 02/2000
4Therapeutics
11/2021 - 07/2013
3Stem Cell Transplantation
05/2005 - 01/2001
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2001 - 02/2000
2Immunotherapy
01/2016 - 02/2015
2Cell Transplantation
07/2013 - 06/2008
1Drug Therapy (Chemotherapy)
01/2018
1Liver Transplantation
02/2015
1Plasmapheresis
05/2002
1Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
01/2001
1Hematopoietic Stem Cell Transplantation
05/2000